Amgen Releases First Quarter 2026 Earnings Report Key Highlights UK Train Operators May Face Reputational Pressure as Police Introduce Sexual Harassment Scoring System SP 500 Edges Higher on Broad Gains Healthcare Leads Escape Rooms and Immersive Gaming Boom Experiential Entertainment as an Investment Opportunity Silver Price Outlook Industrial Demand and Potential for 100 Over the Next Decade Kevin Warsh to Be Sworn In as Federal Reserve Chair on Friday CLLS Q1 2026 Earnings Narrowing Losses as Cost Discipline Surprises to the Upside OCFC Q1 2026 Earnings Earnings Per Share Surpasses Expectations Shares Edge Higher Consensus Cloud Solutions Inc CCSI Q1 2026 Earnings Solid EPS Beat Lifts Sentiment Despite Flat Revenue Picture EVEX Q1 2026 Earnings PreRevenue eVTOL Developer Reports WiderThanExpected Loss Amid Development Progress AMAL Q1 2026 Earnings EPS Falls Short of Estimates Revenue Not Disclosed TSN Q1 2026 Earnings EPS Surpasses Estimates as Protein Demand Holds Steady Moolec Science MLEC Dips 281 as Shares Approach Key Support Level ThredUp Inc TDUP Slips 338 as Broader Market Weakness Weighs on Resale Platform Bon Natural Life Limited BON Slips 157 as It Nears Key Support at 120 CNA Financial Stock Slips Slightly as Shares Trade Near Midpoint of Recent Range Meshflow Warrants MESHW Hold Steady at 030 as Trading Activity Remains Subdued Irans President Orders Reopening of International Internet Access Signal of Policy Shift YI Q3 2024 Earnings Narrowing Loss Per Share Stock Rallies Despite Sparse Data Franklin BSP Realty Trust FBRT Dips Nearly 3 Support Test in Focus LFUS Q1 2026 Earnings Strong EPS Beat Exceeds Analyst Expectations BAH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline QNST Q1 2026 Earnings EPS Falls Short of Estimates Shares Inch Higher MLTX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline WSM Q1 2026 Earnings EPS Surprises with 575 Beat Stock Rises IVVD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress